1. Regulation of ST6GAL1 sialyltransferase expression in cancer cells
- Author
-
Katherine E Ankenbauer, Jihye Hwang, Michael P Marciel, Kaitlyn A. Dorsett, Susan L. Bellis, and Nikita Bhalerao
- Subjects
Regulation of gene expression ,Sialyltransferase ,Cancer ,Review ,Biology ,medicine.disease ,Biochemistry ,Sialyltransferases ,Downregulation and upregulation ,Antigens, CD ,Cancer stem cell ,Neoplasms ,Cancer cell ,Cancer research ,medicine ,biology.protein ,Humans ,Neoplastic transformation ,Epigenetics - Abstract
The ST6GAL1 sialyltransferase, which adds α2–6 linked sialic acids to N-glycosylated proteins, is overexpressed in a wide range of human malignancies. Recent studies have established the importance of ST6GAL1 in promoting tumor cell behaviors such as invasion, resistance to cell stress and chemoresistance. Furthermore, ST6GAL1 activity has been implicated in imparting cancer stem cell characteristics. However, despite the burgeoning interest in the role of ST6GAL1 in the phenotypic features of tumor cells, insufficient attention has been paid to the molecular mechanisms responsible for ST6GAL1 upregulation during neoplastic transformation. Evidence suggests that these mechanisms are multifactorial, encompassing genetic, epigenetic, transcriptional and posttranslational regulation. The purpose of this review is to summarize current knowledge regarding the molecular events that drive enriched ST6GAL1 expression in cancer cells.
- Published
- 2020
- Full Text
- View/download PDF